# AVADEL PHARMACEUTICALS PLC (AVDLXXXX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AVDLXXXX/

- Reporting holders: 1
- Reported value: $16
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [HUNTINGTON NATIONAL BANK](https://holderbook.com/funds/49205-huntington-national-bank/) | $16 | 1 | 0.0% | 15 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $16 |
| Q1 2026 | 1 | $16 |
| Q4 2025 | 2 | $12.9M |
| Q3 2025 | 3 | $11.3M |
| Q2 2025 | 4 | $6.7M |
| Q1 2025 | 3 | $5.8M |
| Q4 2024 | 3 | $7.7M |
| Q3 2024 | 5 | $14.0M |
| Q2 2024 | 10 | $98.8M |
| Q1 2024 | 122 | $1.2B |
| Q4 2023 | 113 | $827.6M |
| Q3 2023 | 100 | $573.7M |